Peter Kolchinsky

Insider Reports History

Location
Boston, MA
Signature
/s/ Matthew Hammond as Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Peter Kolchinsky:

Company Role Class Num Shares Value Price $ Report Date Ownership
Forma Therapeutics Holdings, Inc. Director, 10%+ Owner Common Stock 9,011,651 $45,508,838 $5.05 17 Jun 2021 Indirect
Therapeutics Acquisition Corp. Chief Executive Officer, Director Common Stock 1,098,318 $13,674,059 $12.45 29 Jun 2021 Indirect
Forma Therapeutics Holdings, Inc. Director, 10%+ Owner Common Stock 2,750 $13,888 $5.05 17 Jun 2021 Direct
Forma Therapeutics Holdings, Inc. Director, 10%+ Owner Stock Option (Right to Buy) 8,375 17 Jun 2021 Direct

Insider Reports Filed by Peter Kolchinsky

Symbol Company Period Transactions Value $ Form Type Role Filing Time
/report/000110465921087618-kolchinsky-peter-2021-06-29 Therapeutics Acquisition Corp. 29 Jun 2021 1 +$2,091,000 4 Chief Executive Officer, Director 30 Jun 2021, 16:31
/report/000110465921085291-kolchinsky-peter-2021-06-24 Therapeutics Acquisition Corp. 24 Jun 2021 1 +$8,892,180 4 Chief Executive Officer, Director 24 Jun 2021, 19:08
/report/000089924321025088-kolchinsky-peter-2021-06-17 Forma Therapeutics Holdings, Inc. 17 Jun 2021 2 $0 4 Director, 10%+ Owner 21 Jun 2021, 19:01